Fundraising FoxAraim Pharmaceuticals
Tarrytown, US · Delaware corporation
Find your way into Araim Pharmaceuticals
Sign up to see every warm intro you have to Araim Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Araim Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
SH
Sarah HaleyExecutive
RK
Rita KirkNamed on SEC filing
SS
Sidney StricklandNamed on SEC filing
AC
Anthony CeramiNamed on SEC filing
GB
Gerald BernsteinNamed on SEC filing
MB
Michael BrinesNamed on SEC filing
FB
Ferry BreedveldNamed on SEC filing
JM
John MacomberNamed on SEC filing
AD
Ann DunneNamed on SEC filing
Board
SG
Scott GrundyBoard director
Reported raises · per SEC filings
Form D private placements$8.1M disclosed across 2 rounds · 2014–2017
▶$4.1MraisedNov 2017 · 5 investors · PharmaceuticalsRule 506(b)
▶$4.1MraisedNov 2017 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Rita KirkExecutive Officer
- Sidney StricklandDirector
- Anthony CeramiDirector
- Gerald BernsteinDirector
- Michael BrinesExecutive Officer, Director
- Ferry BreedveldDirector
- John MacomberDirector
- Ann DunneExecutive Officer, Director
- Offering amount
- $4.1M
- Amount sold
- $4.1M
- First sale
- Aug 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4MraisedNov 2014 · 5 investors · PharmaceuticalsRule 506(b)
▶$4MraisedNov 2014 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- John MacomberDirector
- Scott GrundyDirector
- Sarah HaleyExecutive Officer
- Anthony CeramiExecutive Officer, Director
- Michael BrinesExecutive Officer, Director
- Rita KirkExecutive Officer
- Ann DunneExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $4M
- First sale
- Nov 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Araim Pharmaceuticals raised?
- Araim Pharmaceuticals has disclosed $8.1M raised across 2 rounds.
- Where is Araim Pharmaceuticals headquartered?
- Araim Pharmaceuticals is headquartered in Tarrytown, US.